Overview

Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see if the drug colesevelam is a potential treatment for Nonalcoholic Steatohepatitis(NASH).
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Diego
Collaborators:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Treatments:
Colesevelam Hydrochloride